Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
<p>Abstract</p> <p>Background</p> <p>We assessed the incidence of micro-metastases at surgical margins (SM) and pelvic lymph nodes (LN) in patients submitted to radical retropubic prostatectomy (RP) after neoadjuvant therapy (NT) or to RP alone. We compared traditional...
Main Authors: | Baruffi Marco, Blanco Salvatore, Lania Caterina, Grasso Marco, Mocellin Simone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-04-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://www.translational-medicine.com/content/2/1/13 |
Similar Items
-
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01) -
Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01) -
Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01) -
Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
by: Takeshi Sasaki, et al.
Published: (2021-04-01) -
Free PSA: A better molecular marker than total PSA for breast cancer
by: Rachita Nanda
Published: (2014-10-01)